Filter Results:
(611)
Show Results For
- All HBS Web
(1,026)
- People (4)
- News (257)
- Research (611)
- Events (9)
- Multimedia (24)
- Faculty Publications (398)
Show Results For
- All HBS Web
(1,026)
- People (4)
- News (257)
- Research (611)
- Events (9)
- Multimedia (24)
- Faculty Publications (398)
Sort by
- 19 Sep 2012
- Research & Ideas
Funding Innovation: Is Your Firm Doing it Wrong?
programs to an investment board comprising both insiders (senior GSK executives) and outsiders (including a venture capitalist and a biotech CEO). After a three-month review period, successful teams are awarded three years worth of investment funding. Because View Details
Keywords: by Carmen Nobel
- 01 May 2007
- First Look
First Look: May 1, 2007
face major challenges including headline-grabbing litigation, imminent patent expirations, new technologies, rising drug development costs, generic drug substitution, international competitors, and complex... View Details
Keywords: Sean Silverthorne
- 17 Nov 2008
- Research & Ideas
Decoding the Artful Sidestep
There are two findings that we find most interesting. First, it is striking that participants failed to punish the speaker when he dodged the question asked. For example, the speaker paid no price for answering a question about the illegal View Details
Keywords: by Martha Lagace
- 12 May 2008
- Research & Ideas
Accounting Information as Political Currency
information standards in accounting (through the Financial Accounting Standards Board) and in food labeling (through the Food and Drug Administration). There are likely lessons for both regulatory agencies in such a comparative analysis. View Details
Keywords: by Martha Lagace
- 01 Jul 2008
- First Look
First Look: July 1, 2008
establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals business in parallel to its effort to develop anti-aging therapeutics? And, should it in-license a second drug development candidate? Purchase... View Details
Keywords: Martha Lagace
- 19 Jun 2013
- Research & Ideas
Analyzing Institutions to Solve Big Problems
that marijuana was a popular treatment in the nineteenth century, and the drug was listed in the Dispensatory of the United States by the 1850s. The paper looks at how the Federal Bureau of Narcotics managed not only to illegalize the... View Details
Keywords: by Carmen Nobel & Anna Secino
- 23 May 2017
- First Look
First Look at New Ideas and Research: May 23, 2017
Although Novartis would improve its position in oncology by acquiring GSK’s promising drug portfolio, it had to sell its vaccines and animal health businesses, while giving up control of the over-the-counter (OTC) business. Jimenez and... View Details
Keywords: Carmen Nobel
- 11 May 2010
- First Look
First Look: May 11
rapid evolution of the biopharmaceutical industry. In the early 2000s, as Millennium's competitive advantage in early-stage research slipped away and its losses mounted, founder and CEO Mark Levin moved the firm downstream away from research and towards View Details
Keywords: Martha Lagace
- 13 Jul 2009
- Research & Ideas
Diagnosing the Public Health Care Alternative
of its inadequate payments. In the end, the Democrats' health care reform will require drastic rationing of health care for the sick to control its costs. The government-controlled UK health care system points the way because it features, for example, the lowest uptake... View Details
- 13 Sep 2011
- First Look
First Look: September 13
come primarily from the non-drug treatment (87.4% and 70.2% respectively), whereas gains from detailing come at the expense of competing drugs (84%). By contrast, the random coefficient logit model predicts that gains from DTCA, M&E,... View Details
Keywords: Sean Silverthorne
- 18 Sep 2007
- First Look
First Look: September 18, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=907025 NatuRi Corporation Harvard Business School Case 807-027 NatuRi Corporation was a start up, founded in 2005, aiming to manufacture a cholesterol-lowering drug made from... View Details
Keywords: Martha Lagace
- 06 May 2008
- First Look
First Look: May 6, 2008
Fibrosis Foundation: Venture Philanthropy Funding for Biotech Harvard Business School Case 808-005 In 2001, Vertex Pharmaceuticals Incorporated acquired the San Diego-based biotech company, Aurora Biosciences. The combination of Vertex's and Aurora's technologies would... View Details
Keywords: Martha Lagace
- 15 Apr 2008
- First Look
First Look: April 15, 2008
destructive behaviors such as cutting, excessive use of alcohol, taking drugs and suicide attempts. These patients are very difficult to treat and TBC has developed programs that make a noticeable difference to these patients. DBT... View Details
Keywords: Martha Lagace
- 05 Sep 2007
- First Look
First Look: September 5, 2007
value, or derail deals altogether. Consider, for example, the pharmaceutical company that deadlocked with a supplier over the issue of exclusivity in an ingredient purchase. Believing it was a ploy to raise the price, the drug maker upped... View Details
Keywords: Martha Lagace
- 06 Apr 2015
- Research & Ideas
After Germanwings, More Attention Needed on Employee Mental Health
chronic work stress, while only 36 percent reported their employers provided adequate support to manage it. According to the National Institute of Mental Health, some 6.7 percent of American adults experience "major depressive disorder; antidepressants are the most... View Details
- 18 Jun 2001
- Research & Ideas
When In-House Research Isn’t Enough
system: Where are the best people and ideas in your field? "If you believe that knowledge is more and more globally distributed, chances are not all the best people work for you," he declared. Can you control the leakage of ideas? The patent system and... View Details
Keywords: by Jim Aisner
- 23 Aug 2010
- Research & Ideas
The Drive to Acquire’s Impact on Globalization
inherently abusive; the citizens of the developed country are winners and the citizens of the undeveloped country may be getting a better or cheaper product. But when regulation is weak or nonexistent, this system can lend itself to severe abuse, as in the sale of fake... View Details
Keywords: by Paul R. Lawrence
- 19 Oct 2015
- Research & Ideas
Business Research that Makes for Smarter Public Policy
Ginger Jin, of the Maryland Center for Economics and Policy, is just one example. They invited regulatory officials from several leading federal agencies, including the Department of Agriculture (USDA), Environmental Protection Agency (EPA), Food and View Details
Keywords: by Michael Blanding
- 22 Apr 2008
- First Look
First Look: April 22, 2008
Business Harvard Business School Case 608-136 Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in... View Details
Keywords: Martha Lagace
- 16 Jul 2008
- Op-Ed
What Should Employers Do about Health Care?
frequently in search of a better deal, which has meant that their employees needed to switch as well. They have tried to pare back covered services, thrown up barriers to expensive drugs and treatments, and recently, begun to pass more... View Details